Bausch Health Companies Inc, founded in 2017 and headquartered in Laval, Quebec, is a global healthcare company dedicated to transforming the lives of patients through innovative pharmaceutical products. The company specializes in a diverse range of medical and aesthetic products, including ophthalmic solutions, dermatology treatments, and products for gastrointestinal disorders.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Bausch Health began its journey in the bond market shortly after its formation, with noteworthy issuances including a $1.25 billion senior notes offering in 2019, aimed at refinancing existing debt. As of October 2023, its bonds yield around 6.5%, which is competitive compared to the industry average. Notably, Bausch Health's financial strategies have been focused on debt reduction and achieving a sustainable capital structure, positioning the company favorably amid ongoing market conditions.